Bard Ends Vessel Graft Patent Feud With Endologix

Law360, Los Angeles (November 15, 2011, 4:09 PM EST) -- An Arizona federal judge on Tuesday dismissed medical device manufacturer C. R. Bard Inc.’s lawsuit accusing competitor Endologix Inc. of infringing a patent covering a type of prosthetic blood vessel graft, after the parties moved to dismiss the case pursuant to a settlement.

In response to a joint stipulation filed Aug. 10, U.S. District Judge David G. Campbell ordered Bard’s complaint dismissed with prejudice, along with counterclaims for patent invalidity and noninfringement filed by Endologix in December.

The parties agreed to bear all costs and fees,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.